Atrial Fibrillation A National View Dr Matthew Fay General Practitioner Shipley West Yorkshire National Clinical Lead-NHS Improvement-Stroke
Acknowledgements •Dr Campbell Cowan •Dr Andreas Wolff •Dr Arindam Kar •Westcliffe Medical Practice
Costs associated with AF •12,500 strokes annually attributed to AF in UK •DH estimates of costs of strokes attributable to AF •Total cost £148 million in first year •Hospital stay cost £103 million •Post‐discharge care £45 million •Cost per stroke £12,000
Costs attributable to treating AF • Annual cost per patient £ 383 • Costs per stroke averted £9,572 • Additional costs due to major bleeds £ 236 – 349 / patient Treatment saves money and pays for itself
David Nicholson has set the challenge of saving £15-20 billion through efficiency savings from 2011 to 2014. The challenge to the NHS is how to make these savings whilst keeping quality as its organising principle
Role of the centre Improve quality and make efficiency savings
Quality improvements
Efficiency savings
The Department of Health’s role is to help the NHS prepare to meet the QIPP challenge, in line with the four principles of change: - Co-production - Subsidiary - Clinical leadership - System Alignment
5
Stroke prevention in AF Detection of AF
Decision to anti-coagulate
Finding Atrial Fibrillation
Atrial Fibrillation •Commonest sustained Arrhythmia •Increasing in prevelence •Very common •Prevalence of 1.2% •600,000 case in England
PROJECTED AF PREVALENCE OLMSTED COUNTY DATA
12% observed increase in AF incidence between 1980 and 2000
Miyasaka et al, Circulation 2005; 114:119
Atrial Fibrillation •Commonest sustained Arrhythmia •Increasing in prevalence •Very common •Prevalence of 1.2% •600,000 case in England
Really?
Prevalence AF by practice
Direct Comparison
Fitzmaurice, D. A et al. BMJ 2007;335:383
Possible Solutions
Pulse Palpation at Flu Vaccination • Essex Cardiac & Stroke Network • Dr. Max Hickman, Chairman Colchester PBC Group • PBC Business Case August 2008 • LES agreed Sept 2008
[email protected]
18
[email protected]
19
Investigations • • • • •
Cardiovascular examination ECG BP BMI Cholesterol, glucose, creatinine
[email protected]
20
Outcomes 37/43 practices in N E Essex Signed up to LES • 34,201 patients screened in 6 weeks – 3154 Patients found with irregular pulse (9.2%) – 189 Patients found with AF (0.55%) – 342 Patients found with other Arrhythmias (0.99%) including 2 in Complete H. Block!
[email protected]
21
The simple things in life… AF screening in General Practice
Dr Andreas Wolff
16%
National AF Prevalence in 2008: 1.3%
Whinfield Surgery AF prevalence 2008 = 1.32% Whinfield Surgery: patients aged 65 and over = 16%
Whinfield Surgery AF screening programme
Opportunistic computer prompted screening 5/08 – 5/09 1883 patients aged 65 years and older
1569 patients: pulse palpation
207 patients found with irregular pulse
130 patients with irregular pulse and no known AF
99 patients had ECGs
36 patients diagnosed with previously unknown AF ( +19 )
Key Facts • • • • • • •
83.3% screened opportunistically 13% with irregular pulse 6.3% had ECGs 36% had AF on ECG Number needed to screen 43 Change in prevalence 1.32 -> 1.82% Prevalence of 65ys and older: 10.9%
Stroke Prevention
Anticoagulation is underused and suboptimal in high risk patients with atrial fibrillation who present with a stroke ‐ 5 year data Dr Maneesh Bhargava Dr Arindam Kar Dr Richard Perry Dr Diane Ames St Mary’s Hospital Imperial College NHS Trust
UK
Methods y Retrospective analysis of 5 year stroke data from St Mary’s Hospital Stroke Register (2003‐2008) – y
n=1297 total ischaemic strokes
y Subjects of interest – Pre‐existing AF or PAF y High risk stratification according to NICE 2006 criteria y No contraindications to anticoagulation y
• Data collected on – • Prior anticoagulant or antithrombotic use • Admission INR for those on warfarin
Results y 15% (187/1297) patients with ischaemic stroke were known to have AF or PAF.
Results ‐ Demographics Patients with ischaemic stroke and known AF (n=187)
Results High risk as per NICE guidelines: n=156/187
No documented contraindication to warfarin : n=131/156
N=59/131
High risk patients with no contra‐indication to warfarin : (n=131)
Results y Warfarin treated patients (n=35/131): ‐Sub‐therapeutic INR (